The medical emergency team, evidence-based medicine and ethics

被引:15
作者
Kerridge, RK [1 ]
Saul, WP [1 ]
机构
[1] John Hunter Hosp, Div Anaesthesia Intens Care & Pain Management, Newcastle, NSW, Australia
关键词
D O I
10.5694/j.1326-5377.2003.tb05556.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The medical emergency team (MET), which may be summoned by anyone in a hospital to treat a patient who appears acutely unwell, has been generally accepted as scientifically rational, with no adverse clinical outcomes and only modest resource requirements. Despite this, many centres appear to be awaiting "gold standard" evidence of its effectiveness. We suggest that the quest for evidence is providing scientific justification for institutional inertia, and that further delay in implementing this system may even be unethical. We propose that decisions about changes in healthcare should consider scientific rationality, clinical reasonableness and resource implications, as well as evidence and ethical implications.
引用
收藏
页码:313 / 315
页数:3
相关论文
共 21 条
  • [1] BANDOLIER, EVIDENCE BASED THINK
  • [2] A prospective before-and-after trial of a medical emergency team
    Bellomo, R
    Goldsmith, D
    Uchino, S
    Buckmaster, J
    Hart, GK
    Opdam, H
    Silvester, W
    Doolan, L
    Gutteridge, G
    [J]. MEDICAL JOURNAL OF AUSTRALIA, 2003, 179 (06) : 283 - 287
  • [3] Effects of a medical emergency team on reduction of incidence of and mortality from unexpected cardiac arrests in hospital: preliminary study
    Buist, MD
    Moore, GE
    Bernard, SA
    Waxman, BP
    Anderson, JN
    Nguyen, TV
    [J]. BRITISH MEDICAL JOURNAL, 2002, 324 (7334): : 387 - 390
  • [4] A price for cost-effectiveness: Implications for recombinant human activated protein C (rhAPC)
    Chalfin, DB
    Teres, D
    Rapoport, J
    [J]. CRITICAL CARE MEDICINE, 2003, 31 (01) : 306 - 308
  • [5] DEANE SA, 1989, AUST NZ J SURG, V59, P373
  • [6] DOWNEY M, 1997, SYDNEY MORNING 0510, P1
  • [7] Recombinant human activated protein C in sepsis: Inconsistent trial results, an unclear mechanism of action, and safety concerns resulted in labeling restrictions and the need for phase IV trials
    Eichacker, PQ
    Natanson, C
    [J]. CRITICAL CARE MEDICINE, 2003, 31 (01) : S94 - S96
  • [8] INPATIENT GENERAL MEDICINE IS EVIDENCE BASED
    ELLIS, J
    MULLIGAN, I
    ROWE, J
    SACKETT, DL
    [J]. LANCET, 1995, 346 (8972) : 407 - 410
  • [9] Personal paper - Ethics and evidence based medicine
    Kerridge, I
    Lowe, M
    Henry, D
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 1998, 316 (7138): : 1151 - 1153
  • [10] THE MEDICAL EMERGENCY TEAM
    LEE, A
    BISHOP, G
    HILLMAN, KM
    DAFFURN, K
    [J]. ANAESTHESIA AND INTENSIVE CARE, 1995, 23 (02) : 183 - 186